MyVisionTest News Archive

Displaying news items tagged with Lucentis (More tags »)
SELECT PAGE
First <<  9 10 11 12 13 14 15 16 17 18   >> Last

May 9, 2008
The PrONTO study found that as-needed treatment with Lucentis can provide results similar to monthly dosing. Strategies are being developed that decrease the required number of injections and also decrease the number of office visits, thereby improving patient convenience and decreasing overall cost while maintaining visual acuity. We review the...

Full Article


VEGF molecule
May 8, 2008
Bayer HealthCare AG and RegeneronPharmaceuticals, Inc. today announced that the first patient has been dosed in the VIEW 2 trial, a second Phase 3 clinical study in a development program evaluating VEGF Trap-Eye for the treatment of the neovascular form of Age-related Macular Degeneration (wet AMD), a leading cause of blindness in adults. VIEW 2...

Full Article


Medimur Intravitreal Implant
May 8, 2008
pSivida Limited announced today that enrollment has begun for a clinical trial to assess the safety and efficacy of its sustained release steroid implant device (Medidur FA) in conjunction with Lucentis in patients with exudative age-related macular degeneration (wet AMD). The study is designed to provide preliminary information on the potential...

Full Article


Lucentis
May 6, 2008
In a clinical trial comparing the use of ranibizumab against photodynamic therapy (PDT), the number of patients who continued driving their cars increased among those treated with ranibizumab while the rate decreased for those who received PDT according to research presented at the Association for Research in Vision and Ophthalmology 2008 annual...

Full Article


Lucentis
Apr 30, 2008
Early results from the READ-2 study presented Monday at the 2008 Annual Meeting of The Association for Research in Vision and Ophthalmology find that the drug Lucentis (ranibizumab) for the treatment of diabetic eye disease has performed better in clinical trials than the current standard treatment using laser surgery. The multi-center READ-2...

Full Article


Avastin
Apr 29, 2008
There appear to be few meaningful differences other than price between the vascular endothelial growth factor inhibitors Lucentis (ranibizumab) and Avastin (bevacizumab) -- at least in the short term. Researchers presented the results of a retrospective review of patient records at the Association for Research in Vision and Ophthalmology (ARVO)...

Full Article


Apr 18, 2008
A panel of experts discussed controversial issues surrounding the treatment of AMD at the Retina 2008 meeting. Below are excerpts from the transcript published by ONS Supersite. Retina is making history because intravitreal injections are now No. 3 on the list of ophthalmic procedures coded for Medicare reimbursement, following cataract with...

Full Article


Apr 8, 2008
The drug Lucentis is covered for most seniors who have wet age-related macular degeneration no matter when the condition was diagnosed, say the Canadian National Institute for the Blind and the Ministry of Health. Some patients over 65 have been told by the eye clinic at Hotel Dieu in Kingston that the costs of the drug are not covered unless...

Full Article


Apr 2, 2008
The UK Government's rationing body, the National Institute for Health and Clinical Excellence (NICE), will announce the last milestone for its approval of Lucentis today. But it is feared the two-year appraisal has already cost the sight of up to 20,000 sufferers. Some campaigners believe that primary care trusts may be given an extra three...

Full Article

Tags: Lucentis, NHS

SELECT PAGE
First <<  9 10 11 12 13 14 15 16 17 18   >> Last
Most Popular
Less - past - More